MZF1 possesses a repressively regulatory function in ERCC1 expression

Biochemical Pharmacology

Volumn 71, Issue 6, 2006, Pages 761-771

  Yan, Qing Wu ^a,b   Reed, Eddie ^a   Zhong, Xiao Song ^a   Thornton, Keith ^a   Guo, Yi ^a   Yu, Jing Jie ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AP1; Cisplatin resistance; ERCC1; MZF1; NER; Repressor

Indexed keywords

CIS ACTING ELEMENT; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MESSENGER RNA; MYELOID ZINC FINGER PROTEIN 1; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING KINETICS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA DAMAGE; DNA FLANKING REGION; EXCISION REPAIR; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TIME; TRANSCRIPTION REGULATION; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CISPLATIN; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; UP-REGULATION; ZINC FINGERS;

EID: 32144446618     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.12.015     Document Type: Article

References (40)

1. E. Reed, M. Dabholkar, and B.A. Chabner Platinum analogues B.A. Chabner D.L. Longo Cancer chemotherapy 2nd ed. 1996 Lippincott-Raven Publishers Philadelphia 357
2. P.J. Loehrer, and L.H. Einhorn Drugs 5 years later. Cisplatin Ann Intern Med 100 1984 704
3. H. Timmer-Bosscha, N.H. Mulder, and E.G.E. de Vries Modulation of cis-diamminedichloroplatinum(II) resistance: a review Br J Cancer 66 1992 227
4. H. Masuda, R.F. Ozols, G.-M. Lai, A. Fojo, M. Rothenberg, and T.C. Hamilton Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines Cancer Res 48 1988 5713 5716
5. M. Dabholkar, J.A. Vionnet, F. Bostick-Bruton, J.J. Yu, and E. Reed mRNA levels of XPAC and ERCC1 in ovarian tumor tissue correlates with response to platinum containing chemotherapy J Clin Invest 94 1994 703 708
6. B.C. Behrens, T.C. Hamilton, and H. Masuda Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues Cancer Res 47 1987 414 418
7. A. Eastman Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II) Biochemistry 22 1983 3927 3933
8. D.E. Szymkowski, K. Yarema, J.M. Essigmann, S.J. Lippard, and R.D. Wood An intrastrand d(GpG) platinum cross-link in duplex M13 DNA is refractory to repair by human cell extracts Proc Natl Acad Sci USA 89 1992 10772 10776
9. J.C. Jones, W. Zhen, E. Reed, R.J. Parker, A. Sancar, and V.A. Bohr Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells J Biol Chem 266 1991 7101 7107
10. M. Masuda, T. Tanaka, H. Matsuda, and I. Kusaba Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II) Cancer Res 50 1990 1863 1866
11. R.J. Parker, A. Eastman, F. Bostick-Bruton, and E. Reed Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation J Clin Invest 87 1991 772 777
12. S.W. Johnson, R.P. Perez, A.K. Godwin, A.T. Yeung, L.M. Handel, and R.F. Ozols Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines Biochem Pharmacol 47 1994 689 697
13. E. Katz, P. Andrews, and S. Howell The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells Cancer Commun 2 1990 159 164
14. A. Sancar Mechanisms of DNA excision repair Science 266 1994 1954 1956
15. J.G. Moggs, K.J. Yarema, J.M. Essigmann, and R.D. Wood Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct J Biol Chem 271 1996 7177 7186
16. C.H. Park, and A. Sancar Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins Proc Natl Acad Sci USA 91 1994 5017 5021
17. A.J. van Vuuren, E. Appeldoorn, H. Odijk, S. Humbert, V. Moncollin, and A.P. Eker Partial characterization of the DNA repair protein complex containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities Mutat Res 337 1995 25 39
18. K.B. Lee, R.J. Parker, V.A. Bohr, T.C. Cornelison, and E. Reed Cisplatin sensitivity/resistance in UV-repair deficient Chinese hamster ovary cells of complementation groups 1 and 3 Carcinogenesis 14 1993 2177 2180
19. W. Zhen, C.J. Link, P.M. O'Connor, E. Reed, R.J. Parker, and V.A. Bohr Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines Mol Cell Biol 12 1992 3689 3698
20. M. van Duin, J. de Wit, H. Odijk, A. Westerveld, A. Yasui, and H.M. Koken Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10 Cell 44 1986 913 923
21. P. Taverna, J. Hansson, K.J. Scanlon, and B.T. Hill Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity Carcinogenesis 15 1994 2053 2056
22. Q. Li, K. Gardner, L. Zhang, B. Tsang, F. Bostick-Bruton, and E. Reed Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells J Biol Chem 273 1998 23419 23425
23. J.F. Morris, R. Hromas, and F.J. Rauscher Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core Mol Cell Biol 14 1994 1786 1795
24. R. Hromas, S.J. Collins, D. Hickstein, W. Raskind, L.L. Deaven, and P. O'Hara A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells J Biol Chem 266 1991 14183 14187
25. J.F. Morris, F.J. Rauscher, B. Davis, M. Klemsz, D. Xu, and D. Tenen The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro Blood 86 1995 3640 3647
26. D. Perrotti, P. Melotti, T. Skorski, I. Casella, C. Peschle, and B. Calabretta Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-Myc promoter activity Mol Cell Biol 15 1995 6075 6087
27. R. Hromas, S. Boswell, R.N. Shen, G. Burgess, A. Davidson, and K. Cornetta Forced overexpression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells Leukemia 10 1996 1049 1050
28. R. Hromas, B. Davis, F.J. Rauscher, M. Klemsz, D. Tenen, and S. Hoffman Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1 Curr Top Microbiol Immunol 211 1996 159 164
29. K. Quandt, K. Frech, H. Karas, E. Wingender, and T. Werner MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data Nucl Acids Res 23 1995 4878 4884
30. E. Wingender, X. Chen, R. Hehl, H. Karas, I. Liebich, and V. Matys TRANSFAC: an integrated system for gene expression regulation Nucl Acids Res 28 2000 316 319
31. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
32. J.P. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucl Acids Res 11 1983 1475 1489
33. B. Wasylyk, C. Wasylyk, P. Flores, A. Begue, D. Leprince, and D. Stehelin The c-Ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation Nature 346 1990 191 193
34. C.J. Schoenherr, and D.J. Anderson The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes Science 267 1995 1360 1363
35. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 270 1995 16483 16486
36. M. Gottlicher, H.J. Rahmsdorf, and P. Herrlich The regulation of AP-1 activity by mitogen-activated protein kinases A.G. Papavassiliou Transcription factors in eukaryotes 1997 Landes Bioscience Austin, TX 67
37. C. Abate, D. Luk, and T. Curran Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains Mol Cell Biol 11 1991 3624 3632
38. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, and H.J. Rahmsdorf Phorbol ester-inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor Cell 49 1987 729 739
39. P. Hui, X. Guo, and P.G. Bradford Isolation and functional characterization of the human gene encoding the myeloid zinc finger protein MZF-1 Biochemistry 34 1995 16493 16502
40. S.M. Hoffman, R. Hromas, C. Amemiya, and H.W. Mohrenweiser The location of MZF-1 at the telomere of human chromosome 19q makes it vulnerable to degeneration in aging cells Leuk Res 20 1996 281 283